Foamix Pharmaceuticals Ltd. Stock price Nasdaq
Equities
IL0011334385
Pharmaceuticals
Financials (USD)
Sales 2024 * | 400K | Sales 2025 * | 250K | Capitalization | 41.73M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -40M | EV / Sales 2024 * | 104 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 167 x |
P/E ratio 2024 * |
-2.96
x | P/E ratio 2025 * |
-3.08
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.3% |
Latest transcript on Foamix Pharmaceuticals Ltd.
Managers | Title | Age | Since |
---|---|---|---|
David Domzalski
CEO | Chief Executive Officer | 58 | 20-02-29 |
Tyler Zeronda
DFI | Director of Finance/CFO | 38 | - |
Iain Stuart
CTO | Chief Tech/Sci/R&D Officer | 51 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pat LePore
BRD | Director/Board Member | 69 | 20-09-09 |
Steven Basta
BRD | Director/Board Member | 59 | 14-12-31 |
Anthony Bruno
BRD | Director/Board Member | 68 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.80% | 210B | |
+1.02% | 210B | |
-6.65% | 201B | |
-3.51% | 157B |